CVS Agrees to Pay $8 Million to Settle DEA Allegations Against Maryland Stores

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Enforcement

CVS Agrees to Pay $8 Million to Settle DEA Allegations Against Maryland Stores

Joan Flynn

February 24, 2016 at 10:05:00 ET

CVS has agreed to pay $8 million to settle allegations that its Maryland pharmacies dispensed oxycodone, fentanyl and other controlled substances without ensuring that the prescriptions were lawfully issued for a legitimate medical purpose. CVS has admitted that between 2008 and 2012 some pharmacy stores in Maryland dispensed the highly addictive drugs in a manner not fully consis... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

CVS Agrees to Pay $8 Million to Settle DEA Allegations Against Maryland Stores

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT